• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用合成糖肽模拟HIV广泛中和抗体表位。

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.

作者信息

Alam S Munir, Aussedat Baptiste, Vohra Yusuf, Meyerhoff R Ryan, Cale Evan M, Walkowicz William E, Radakovich Nathan A, Anasti Kara, Armand Lawrence, Parks Robert, Sutherland Laura, Scearce Richard, Joyce M Gordon, Pancera Marie, Druz Aliaksandr, Georgiev Ivelin S, Von Holle Tarra, Eaton Amanda, Fox Christopher, Reed Steven G, Louder Mark, Bailer Robert T, Morris Lynn, Abdool-Karim Salim S, Cohen Myron, Liao Hua-Xin, Montefiori David C, Park Peter K, Fernández-Tejada Alberto, Wiehe Kevin, Santra Sampa, Kepler Thomas B, Saunders Kevin O, Sodroski Joseph, Kwong Peter D, Mascola John R, Bonsignori Mattia, Moody M Anthony, Danishefsky Samuel, Haynes Barton F

机构信息

Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.

Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.

出版信息

Sci Transl Med. 2017 Mar 15;9(381). doi: 10.1126/scitranslmed.aai7521.

DOI:10.1126/scitranslmed.aai7521
PMID:
28298421
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5562351/
Abstract

A goal for an HIV-1 vaccine is to overcome virus variability by inducing broadly neutralizing antibodies (bnAbs). One key target of bnAbs is the glycan-polypeptide at the base of the envelope (Env) third variable loop (V3). We have designed and synthesized a homogeneous minimal immunogen with high-mannose glycans reflective of a native Env V3-glycan bnAb epitope (Man-V3). V3-glycan bnAbs bound to Man-V3 glycopeptide and native-like gp140 trimers with similar affinities. Fluorophore-labeled Man-V3 glycopeptides bound to bnAb memory B cells and were able to be used to isolate a V3-glycan bnAb from an HIV-1-infected individual. In rhesus macaques, immunization with Man-V3 induced V3-glycan-targeted antibodies. Thus, the Man-V3 glycopeptide closely mimics an HIV-1 V3-glycan bnAb epitope and can be used to isolate V3-glycan bnAbs.

摘要

一种HIV-1疫苗的目标是通过诱导广泛中和抗体（bnAbs）来克服病毒变异性。bnAbs的一个关键靶点是包膜（Env）第三个可变环（V3）基部的聚糖-多肽。我们设计并合成了一种均一的最小免疫原，其具有反映天然Env V3-聚糖bnAb表位的高甘露糖聚糖（Man-V3）。V3-聚糖bnAbs以相似的亲和力与Man-V3糖肽和天然样gp140三聚体结合。荧光团标记的Man-V3糖肽与bnAb记忆B细胞结合，并能够用于从一名HIV-1感染个体中分离出一种V3-聚糖bnAb。在恒河猴中，用Man-V3免疫诱导了靶向V3-聚糖的抗体。因此，Man-V3糖肽紧密模拟HIV-1 V3-聚糖bnAb表位，可用于分离V3-聚糖bnAbs。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/bb8ac4a09f5d/nihms862121f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/0f0942370e97/nihms862121f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/be5e0fccb6c7/nihms862121f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/064c6f6f9924/nihms862121f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/bb8ac4a09f5d/nihms862121f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/0f0942370e97/nihms862121f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/be5e0fccb6c7/nihms862121f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/064c6f6f9924/nihms862121f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5afb/5562351/bb8ac4a09f5d/nihms862121f4.jpg

相似文献

1
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.用合成糖肽模拟HIV广泛中和抗体表位。
Sci Transl Med. 2017 Mar 15;9(381). doi: 10.1126/scitranslmed.aai7521.
2
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates.疫苗在非人灵长类动物中诱导产生针对V3聚糖广泛中和表位的高甘露糖依赖性中和抗体。
Cell Rep. 2017 Feb 28;18(9):2175-2188. doi: 10.1016/j.celrep.2017.02.003.
3
HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope.HIV包膜V3区模拟物体现了一种广泛中和抗体谱系表位的关键特征。
Nat Commun. 2018 Mar 16;9(1):1111. doi: 10.1038/s41467-018-03565-6.
4
Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.人免疫缺陷病毒1型表面抗原上的N-连接聚糖在调节病毒对针对受体和共受体结合位点的广泛中和抗体敏感性方面的保守作用。
J Virol. 2015 Oct 28;90(2):829-41. doi: 10.1128/JVI.02321-15. Print 2016 Jan 15.
5
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope.高活性 V3 糖基化结构域广泛中和抗体与天然糖基化 HIV-1 包膜复合物的结构特征。
Nat Commun. 2018 Mar 28;9(1):1251. doi: 10.1038/s41467-018-03632-y.
6
Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses.合成三组分 HIV-1 V3 糖肽免疫原诱导糖依赖性抗体反应。
Cell Chem Biol. 2017 Dec 21;24(12):1513-1522.e4. doi: 10.1016/j.chembiol.2017.09.005. Epub 2017 Oct 26.
7
Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.菌株特异性反应与广泛中和反应之间的协同作用限制了病毒逃逸，并延长了广泛中和表位的暴露时间。
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00828-17. Print 2017 Sep 15.
8
Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition.合成 HIV V3 糖肽免疫原携带 N334 N-聚糖诱导具有广泛识别表位的糖依赖性抗体。
J Med Chem. 2018 Nov 21;61(22):10116-10125. doi: 10.1021/acs.jmedchem.8b01290. Epub 2018 Nov 8.
9
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.糖基工程化 HIV-1 Env 产生“超级充电”和“杂交”聚糖，以提高中和抗体的效力、广度和饱和度。
PLoS Pathog. 2018 May 2;14(5):e1007024. doi: 10.1371/journal.ppat.1007024. eCollection 2018 May.
10
Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding.来自一名供体的多种抗体谱系靶向HIV-1包膜糖蛋白的聚糖-V3超位点，并表现出对四级结合的偏好。
J Virol. 2016 Nov 14;90(23):10574-10586. doi: 10.1128/JVI.01012-16. Print 2016 Dec 1.

引用本文的文献

1
Selection of Cyclized, Glycosylated Peptide Antigens That Tightly Bind HIV High Mannose Patch Antibodies.紧密结合HIV高甘露糖补丁抗体的环化糖基化肽抗原的筛选
ACS Cent Sci. 2025 Jun 12;11(7):1122-1134. doi: 10.1021/acscentsci.5c00539. eCollection 2025 Jul 23.
2
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin.重复模块和 N-连接聚糖定义了关键肠致病性大肠杆菌黏附素的结构和抗原性。
PLoS Pathog. 2024 Sep 16;20(9):e1012241. doi: 10.1371/journal.ppat.1012241. eCollection 2024 Sep.
3
Synthesis and Structure Optimization of Star Copolymers as Tunable Macromolecular Carriers for Minimal Immunogen Vaccine Delivery.

本文引用的文献

1
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.HIV-1聚糖依赖性广泛中和抗体的阶段性诱导
Sci Transl Med. 2017 Mar 15;9(381). doi: 10.1126/scitranslmed.aai7514.
2
Complex Antigens Drive Permissive Clonal Selection in Germinal Centers.复杂抗原驱动生发中心的许可性克隆选择。
Immunity. 2016 Mar 15;44(3):542-552. doi: 10.1016/j.immuni.2016.02.010. Epub 2016 Mar 3.
3
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.V1V2定向的CAP256-VRC26谱系的新成员，具有增强的广度和卓越的效力。
星形嵌段共聚物的合成与结构优化作为可调节的大分子载体用于最小免疫原疫苗传递。
Bioconjug Chem. 2024 Aug 21;35(8):1218-1232. doi: 10.1021/acs.bioconjchem.4c00273. Epub 2024 Jul 31.
4
SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition.SARS-CoV-2 奥密克戎 XBB 谱系刺突结构、构象、抗原性和受体识别。
Mol Cell. 2024 Jul 25;84(14):2747-2764.e7. doi: 10.1016/j.molcel.2024.06.028.
5
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic .重复模块和N-连接聚糖决定了一种关键产肠毒素菌的结构和抗原性。
bioRxiv. 2024 May 8:2024.05.08.593125. doi: 10.1101/2024.05.08.593125.
6
Bringing immunofocusing into focus.聚焦免疫聚焦技术。
NPJ Vaccines. 2024 Jan 9;9(1):11. doi: 10.1038/s41541-023-00792-x.
7
Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques.疫苗诱导猕猴体内具有模拟 CD4 的 HIV-1 广谱中和抗体前体。
Cell. 2024 Jan 4;187(1):79-94.e24. doi: 10.1016/j.cell.2023.12.002.
8
Prophylactic HIV-1 vaccine trials: past, present, and future.预防性 HIV-1 疫苗试验：过去、现在和未来。
Lancet HIV. 2024 Feb;11(2):e117-e124. doi: 10.1016/S2352-3018(23)00264-3. Epub 2023 Dec 20.
9
Broadly neutralizing antibodies targeting HIV: Progress and challenges.广谱中和抗体靶向 HIV：进展与挑战。
Clin Immunol. 2023 Dec;257:109809. doi: 10.1016/j.clim.2023.109809. Epub 2023 Oct 16.
10
Vaccination induces HIV broadly neutralizing antibody precursors in humans.接种疫苗可在人体内诱导产生 HIV 广谱中和抗体前体。
Science. 2022 Dec 2;378(6623):eadd6502. doi: 10.1126/science.add6502.
J Virol. 2015 Oct 14;90(1):76-91. doi: 10.1128/JVI.01791-15. Print 2016 Jan 1.
4
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.HIV-1疫苗。由类天然包膜三聚体诱导产生的HIV-1中和抗体。
Science. 2015 Jul 10;349(6244):aac4223. doi: 10.1126/science.aac4223. Epub 2015 Jun 18.
5
Designing synthetic vaccines for HIV.设计用于治疗艾滋病病毒的合成疫苗。
Expert Rev Vaccines. 2015 Jun;14(6):815-31. doi: 10.1586/14760584.2015.1027690. Epub 2015 Mar 31.
6
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.在RV144 HIV-1疫苗试验中，抗体轻链对免疫压力位点的限制性识别在系统发育上是保守的。
Immunity. 2014 Dec 18;41(6):909-18. doi: 10.1016/j.immuni.2014.11.014. Epub 2014 Nov 29.
7
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex.重组HIV包膜三聚体筛选出靶向三聚体顶端的四级依赖性抗体。
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17624-9. doi: 10.1073/pnas.1415789111. Epub 2014 Nov 24.
8
Structure and immune recognition of trimeric pre-fusion HIV-1 Env.三聚体融合前HIV-1包膜糖蛋白的结构与免疫识别
Nature. 2014 Oct 23;514(7523):455-61. doi: 10.1038/nature13808. Epub 2014 Oct 8.
9
Transplanting supersites of HIV-1 vulnerability.移植HIV-1易感性的超位点。
PLoS One. 2014 Jul 3;9(7):e99881. doi: 10.1371/journal.pone.0099881. eCollection 2014.
10
Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation.重建 B 细胞克隆谱系。二、突变、选择和亲和力成熟。
Front Immunol. 2014 Apr 22;5:170. doi: 10.3389/fimmu.2014.00170. eCollection 2014.